Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?

BACKGROUND: Widely access to interferon-free direct-acting antiviral regimens (IFN-free DAA) is poised to dramatically change the impact of the HCV epidemic among people who inject drugs (PWID). We evaluated the long-term effect of increasing HCV testing, treatment and engagement into harm-reduction...

Descripción completa

Detalles Bibliográficos
Autores principales: Lima, Viviane D., Rozada, Ignacio, Grebely, Jason, Hull, Mark, Lourenco, Lillian, Nosyk, Bohdan, Krajden, Mel, Yoshida, Eric, Wood, Evan, Montaner, Julio S. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669174/
https://www.ncbi.nlm.nih.gov/pubmed/26633652
http://dx.doi.org/10.1371/journal.pone.0143836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669174/
https://www.ncbi.nlm.nih.gov/pubmed/26633652
http://dx.doi.org/10.1371/journal.pone.0143836

Ejemplares similares